BIOLASE, Inc. (BIOLQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0075
+0.0001 (1.35%)
Dec 20, 2024, 12:01 PM EST
BIOLASE Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 46.03 | 49.16 | 48.46 | 39.19 | 22.78 | 37.8 | Upgrade
|
| Revenue Growth (YoY) | -7.44% | 1.45% | 23.67% | 72.03% | -39.73% | -18.10% | Upgrade
|
| Cost of Revenue | 30.18 | 32.44 | 32.55 | 23.36 | 16.61 | 23.51 | Upgrade
|
| Gross Profit | 15.85 | 16.72 | 15.91 | 15.83 | 6.17 | 14.29 | Upgrade
|
| Selling, General & Admin | 23.65 | 27.86 | 33.98 | 27 | 21.01 | 25.14 | Upgrade
|
| Research & Development | 4.92 | 6 | 7.27 | 6.25 | 3.7 | 4.77 | Upgrade
|
| Operating Expenses | 28.57 | 33.86 | 41.25 | 33.25 | 24.71 | 29.91 | Upgrade
|
| Operating Income | -12.72 | -17.14 | -25.34 | -17.42 | -18.54 | -15.62 | Upgrade
|
| Interest Expense | -2.42 | -2.36 | -2.75 | -2.22 | -2.36 | -2.16 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.11 | -0.35 | -0.44 | -0.45 | -0.02 | -0.12 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.04 | 0.05 | - | - | 4.22 | - | Upgrade
|
| EBT Excluding Unusual Items | -15.2 | -19.8 | -28.53 | -20.09 | -16.7 | -17.9 | Upgrade
|
| Asset Writedown | -0.8 | -0.8 | - | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | -0.32 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 4.31 | - | - | Upgrade
|
| Pretax Income | -16 | -20.6 | -28.53 | -16.09 | -16.7 | -17.9 | Upgrade
|
| Income Tax Expense | 0.04 | 0.03 | 0.11 | 0.07 | 0.13 | -0.04 | Upgrade
|
| Net Income | -16.04 | -20.63 | -28.63 | -16.16 | -16.83 | -17.86 | Upgrade
|
| Preferred Dividends & Other Adjustments | -0.07 | 16.99 | 0.22 | 0.55 | 17.38 | - | Upgrade
|
| Net Income to Common | -15.97 | -37.62 | -28.85 | -16.7 | -34.21 | -17.86 | Upgrade
|
| Shares Outstanding (Basic) | 23 | 1 | 0 | 0 | 0 | - | Upgrade
|
| Shares Outstanding (Diluted) | 23 | 1 | 0 | 0 | 0 | - | Upgrade
|
| Shares Change (YoY) | 4128.33% | 1752.17% | 16.95% | 141.31% | - | - | Upgrade
|
| EPS (Basic) | -0.71 | -29.44 | -418.13 | -283.12 | -1399.06 | - | Upgrade
|
| EPS (Diluted) | -0.71 | -29.44 | -418.13 | -283.12 | -1399.06 | - | Upgrade
|
| Free Cash Flow | -13.68 | -15.4 | -30.49 | -17.42 | -12.89 | -12.95 | Upgrade
|
| Free Cash Flow Per Share | -0.60 | -12.05 | -441.86 | -295.20 | -527.24 | - | Upgrade
|
| Gross Margin | 34.44% | 34.02% | 32.83% | 40.39% | 27.10% | 37.80% | Upgrade
|
| Operating Margin | -27.63% | -34.86% | -52.28% | -44.44% | -81.37% | -41.33% | Upgrade
|
| Profit Margin | -34.69% | -76.52% | -59.53% | -42.63% | -150.16% | -47.24% | Upgrade
|
| Free Cash Flow Margin | -29.72% | -31.33% | -62.91% | -44.44% | -56.59% | -34.27% | Upgrade
|
| EBITDA | -10.1 | -14.34 | -24.84 | -17.02 | -18.04 | -14.64 | Upgrade
|
| EBITDA Margin | -21.94% | -29.17% | -51.26% | -43.42% | -79.18% | -38.73% | Upgrade
|
| D&A For EBITDA | 2.62 | 2.8 | 0.5 | 0.4 | 0.5 | 0.98 | Upgrade
|
| EBIT | -12.72 | -17.14 | -25.34 | -17.42 | -18.54 | -15.62 | Upgrade
|
| EBIT Margin | -27.63% | -34.86% | -52.28% | -44.44% | -81.37% | -41.33% | Upgrade
|
| Advertising Expenses | - | 0.8 | 1.5 | 1.4 | 0.6 | 0.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.